United Therapeutics | Ventas



Sales Cambio Fecha
Amarin USD 42.3M 25.19M 2024-09
Ardelyx USD 116.13M 17.89M 2024-12
Baxter International USD 2.75B 54M 2024-12
Bayer EUR 11.73B 1.76B 2024-12
Biogen USD 2.45B 11.1M 2024-12
BioMarin Pharmaceutical USD 747.31M 1.57M 2024-12
Gilead Sciences USD 7.57B 24M 2024-12
GlaxoSmithKline GBP 8.12B 108M 2024-12
Halozyme Therapeutics USD 298.01M 7.92M 2024-12
Insmed USD 104.44M 11.02M 2024-12
Intra Cellular Therapies USD 199.22M 23.85M 2024-12
Ionis Pharmaceuticals USD 226.58M 92.76M 2024-12
J&J USD 22.52B 49M 2024-12
Moderna USD 966M 896M 2024-12
Pfizer USD 17.76B 61M 2024-12
PTC Therapeutics USD 213.17M 16.39M 2024-12
Regeneron Pharmaceuticals USD 3.79B 70M 2024-12
Sarepta Therapeutics USD 658.41M 191.24M 2024-12
Teva Pharmaceutical Industries USD 15.33B 11B 2024-12
United Therapeutics USD 735.9M 13M 2024-12
Vertex Pharmaceuticals USD 2.91B 140.1M 2024-12



United Therapeutics Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.